30 / 48
30
Preliminary Scientific Programme /
Symposia
WFSBP 2017
T6: BIPOLAR DISORDERS: BASIC/CLINICAL
S-50
11:15–12:45
Real time assessment of psychopathology and behavior
in Bipolar Disorder (BP) using e-mental health
technologies
Chair:
Lars Kessing, Denmark
Co-Chair: Michael Bauer, Germany
S-50-001
Mood instability and Bipolar Disorder (BD): Deriv-
ing useful biosignatures from multidimensional, time
stamped, streamed data
John Geddes, United Kingdom
S-50-002
Smartphone based ambulatory assessment of early
warning signs in Bipolar Disorder (BP)
Michael Bauer, Germany
S-50-003
Smartphones as objective electronic behavioral bio-
markers of illness activity in Bipolar Disorder (BP)
Lars Kessing, Denmark
S-50-004
Voice recognition as objective electronic behavioral
biomarkers of illness activity in Bipolar Disorder (BP)
Maria Fauerholt-Jepsen, Denmark
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
S-51
15:00–16:30
Advances in biomarker development for
neurostimulation
Chair:
Paul Croarkin, USA
Co-Chair: Motoaki Nakamura, Japan
S-51-001
Stimulation-induced neuroplasticity of prefrontal cortex
in adult autism spectrum disorder
Motoaki Nakamura, Japan
S-51-002
Glutamatergic biomarker development for repetitive
transcranial magnetic stimulation
Paul Croarkin, USA
S-51-003
Neurocognitive effects of major depressive disorder and
neurostimulation therapies
Shawn McClintock, USA
S-51-004
Predicting remission of suicidal ideation following
Magnetic Seizure Therapy (MST) in patients with treat-
ment-resistant depression
Zafiris J. Daskalakis, Canada
T3: ANTIPSYCHOTICS: BASIC/CLINICAL
S-52
15:00–16:30
The G protein coupled receptors as a target for
psychotropic drugs
Chair:
Andrzej Pilc, Polan
Co-Chair: Jeffrey P. Conn, USA
S-52-001
Positive allosteric modulators of GPCRs as a novel treat-
ment for schizophrenia
Jeffrey P. Conn, USA
S-52-002
The mGlu5 receptor imaging in schizophrenia and
depression
Gregor Hasler, Switzerland
S-52-003
The mGlu2/3 receptor as a novel therapeutic target for
treatment-resistant depression
Shigeyuki Chaki, Japan
S-52-004
The allosteric modulation of group III mGlu receptors
as target for antipsychotic or antidepressant drugs
Andrzej Pilc, Poland
T49: SUICIDE: BASIC/CLINICAL
S-53
15:00–16:30
Suicidal behavior: Neurobiological and genetic
determinants
Chair:
Yogesh Dwivedi, USA
S-53-001
Epigenetic modifications in brain of suicide individ-
uals: Focus on global and site-specific changes in
5-hydroxymethylcytosine
Gustavo Turecki, Canada
S-53-002
Genetics of intermediate phenotypes for suicidal
behavior: Focus on impulsivity and aggression
Dan Rujescu, Germany
S-53-003
Toxoplasmagondii seropositivity and suicidal behavior
Teodor Postalache, USA
WED